Altarac David 4

4 · Entasis Therapeutics Holdings Inc. · Filed Jan 19, 2021

Insider Transaction Report

Form 4
Period: 2021-01-15
Altarac David
Chief Medical Officer
Transactions
  • Award

    Common Stock

    2021-01-15+25,00025,000 total

Documents

1 file
  • 4
    tm213545-2_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT